Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
JPGN Rep ; 4(4): e367, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38034425

RESUMO

Goat milk is gaining popularity in the United States as an alternative to cow and soy milk. The milk is presented as a healthier and less allergenic alternative, with casein and more MCT oil. The interest in goat milk has increased significantly with the recent formula shortage. Goat milk is available in many forms in the United States, including liquid and powdered formulations. However, there are no approved infant formulas in the United States that are goat milk-based. This case describes an infant who became critically ill due to family confusion over goat milk feeds, highlighting the importance of understanding the nutritional components and safety of various goat milk formulations.

2.
J Pediatr Gastroenterol Nutr ; 76(6): 737-742, 2023 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-36800281

RESUMO

BACKGROUND: The clinical features of pediatric cyclic vomiting syndrome (CVS) often evolve over time. Many patients develop a constellation of chronic symptoms that suggest autonomic nervous system (ANS) dysfunction during adolescence. We aimed to determine the proportion of children with CVS who develop chronic rather than episodic symptoms consistent with ANS dysfunction. METHODS: Retrospective chart review of children ages 0-18 years followed in an outpatient tertiary care CVS center. Patients completed standardized questionnaires at intake and follow-up visits, documenting clinical symptom pattern. Continuous variables are summarized as median [interquartile range (IQR)]. A Mann-Whitney test was used for group comparisons. RESULTS: One hundred subjects were included. A total of 40% developed symptoms of ANS dysfunction (ANS+); 20% were confirmed by comprehensive ANS testing, 11% by orthostatic vital sign abnormalities, and 9% by clinical symptoms. The median (IQR) age at onset of chronic symptoms was 14 (10.02, 15) years. The presence of another disorder of gut-brain interaction ( P = 0.018) and a greater number of comorbidities ( P = 0.031) were more common in the ANS+ group. ANS+ subjects missed more school days ( P = 0.047) and were seen less frequently in the emergency department ( P = 0.023). CONCLUSIONS: Many children with CVS (40%) develop symptoms consistent with clinical dysautonomia in adolescence. These patients experience more comorbid conditions and a greater impact on school attendance, possibly representing a worsened quality of life as their disease course transitions to daily symptoms. When symptoms of CVS change over time, therapeutic interventions may need to be adjusted and targeted accordingly.


Assuntos
Disautonomias Primárias , Qualidade de Vida , Adolescente , Humanos , Criança , Estudos Retrospectivos , Vômito/etiologia , Vômito/tratamento farmacológico , Disautonomias Primárias/diagnóstico , Disautonomias Primárias/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...